Cargando…
THU461 Severe Hypercalcemia Associated With Perinatal Hypophosphatasia While Receiving Enzyme Replacement Therapy
Disclosure: M. Salama: None. P.J. Tebben: None. Introduction: Hypophosphatasia (HPP) is characterized by defective bone mineralization due to reduced function of tissue non-specific alkaline phosphatase (TNSALP) from pathogenic ALPL gene variants. Initial presentation varies according to the clinica...
Autores principales: | Salama, Mostafa, Tebben, Peter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555444/ http://dx.doi.org/10.1210/jendso/bvad114.422 |
Ejemplares similares
-
THU457 Variable Presentations Of Hypophosphatasia In Two Patients In The Outpatient Setting
por: Elmaaz, Ahmed, et al.
Publicado: (2023) -
THU460 A Case Series Of Hypophosphatasia: Presentation And Response To Asfotase Alfa
por: Alsarraf, Farah, et al.
Publicado: (2023) -
THU459 Hypophosphatasia With Normal ALPL Gene Test; A Case Report
por: Alkwatli, Kenda, et al.
Publicado: (2023) -
THU458 Demineralization Zebras: A Rare Case Of Hypophosphatasia In An Adult Presenting With Osteopenia
por: Ramchandani, Bhanvi Prakash, et al.
Publicado: (2023) -
THU410 Retrospective Review Of Adults Patients With Suspected Or Confirmed Hypophosphatasia At The Penn Bone Center
por: Tran, Richie, et al.
Publicado: (2023)